Vertex Pharmaceuticals (NASDAQ: VRTX) just snagged its second U.S. Food and Drug Administration (FDA) approval in only 41 ...

Driven by rapid innovations and the integration of modern technologies, the biotech sector is experiencing robust growth.

"Sanofi continues to prioritize our pipeline to focus on medicines and vaccines that deliver the greatest value for patients," a company spokesperson told Fierce Biotech in an emailed statement.

CAR T–focused biotech Cargo Therapeutics surprised and disappointed analysts when it announced that it would discontinue a ...

It was a busy week for the biotech sector, with regulatory and pipeline updates. Sage Therapeutics SAGE was in focus after it ...

Roche has given two early-phase bispecifics the heave-ho, ending work on a HER2xCD3 prospect and an IL-15 candidate it picked ...

The biotech scene can be seen as fairly risky for new investors who want to put money to work. After all, it’s really tough ...

Iovance Biotherapeutics (IOVA -0.96%), a small-cap biotech company, has an innovative approach to treating cancer that relies ...

Evaxion Biotech A/S announced the successful closing ... $10.8 million to advance its AI-Immunology™ powered vaccine pipeline and cover operational costs. The offering was priced at $2.71 ...

Beyond Carvykti, Legend Biotech boasts a diverse pipeline that provides optionality for future growth. The company is exploring Carvykti's potential in earlier lines of treatment, with ongoing ...

Beyond Carvykti, Legend Biotech boasts a diverse pipeline that provides optionality for future growth. The company is exploring Carvykti's potential in earlier lines of treatment, with ongoing trials ...